238 Dean et al.: Translation of vascular tissue engineering to pediatric CHD 45. Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W. Monocyte activation in angiogenesis and collateral growth in the rab- bit hindlimb. J Clin Invest. 1998;101(1):40- 50. 46. Danenberg HD, Fishbein I, Gao J, et al. Macrophage depletion by clodronate-con- taining liposomes reduces neointimal forma- tion after balloon injury in rats and rabbits. Circulation. 2002;106(5):599-605. 47. Hibino N, Villalona G, Pietris N, Duncan DR, Schoffner A, Roh JD, et al. Tissue-engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood ves- sel. FASEB J. 2011;25(8):2731-9. 48. Harrington JK, Chahboune H, Criscione JM, Li AY, Hibino N, Yi T, et al. Determining the fate of seeded cells in venous tissue-engi- neered vascular grafts using serial MRI. FASEB J. 2011;25(12):4150-61. 49. Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tis- sue remodelling. Nat Rev Mol Cell Biol. 2007;8(3):221-33. 50. Naito Y, Williams-fritze M, Duncan DR, Church SN, Hibino N, Madri JA, et al. Char- acterization of the natural history of extracel- lular matrix production in tissue-engineered vascular grafts during neovessel formation. Cells Tissues Organs (Print). 2012;195(1- 2):60-72. 51. Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA. Smooth muscle cell migra- tion and matrix metalloproteinase expression after arterial injury in the rat. Circ Res. 1994;75(3):539-45. 52. Godin D, Ivan E, Johnson C, Magid R, Galis ZS. Remodeling of carotid artery is associated with increased expression of matrix metallo- proteinases in mouse blood flow cessation model. Circulation. 2000;102(23):2861-6. 53. Shinoka T, Breuer C. Tissue-engineered blood vessels in pediatric cardiac surgery. Yale J Biol Med. 2008;81(4):161-6. 54. Breuer CK. The development and translation of the tissue-engineered vascular graft. J Pe- diatr Surg. 2011;46(1):8-17.